Strides Arcolab, South African Firm Agree on Assets Swap

Pharmaceutical companies Strides Arcolab (Bangalore, India) and Aspen (Durban, South Africa) say they have agreed on a partnership that includes asset swaps. Aspen will buy 50% of Strides’s Latin American operations, valued at about $260 million, under the terms of the deal. Aspen will initially pay $58.5 million and will later subscribe to newly issued Strides shares worth $94 million. Strides, meanwhile, will acquire 51% of generics company Co Pharma Ltd. (Watford, U.K.), an Aspen subsidiary, for about $6 million and acquire an 80% stake in nutraceuticals...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers